With antimicrobial resistance, if anyone is left behind, we're all two steps back.

My research interests focus on exploring the complex connections between structural inequalities and antimicrobial resistance (AMR), especially within high-income countries like the UK where these inequalities largely go unchallenged. AMR is not merely a scientific problem, but a multifaceted global crisis driven by social determinants of health—the non-medical factors that influence and determine health outcomes. Addressing it requires an interdisciplinary understanding of how disparities between different groups and communities, including their access to healthcare, socioeconomic status and working conditions, contribute to the emergence and transmission of drug-resistant infections.

My aim is to bridge the gap between microbiology in the lab and its real-world applications, ensuring my research translates into health solutions grounded in equity and justice. This translational approach is crucial in driving microbiological research that moves beyond academic circles and produces material societal benefits, especially for the people and communities disproportionately impacted.